INS and Insulin resistance: Fasting plasma insulin (FPI), the homeostasis model assessment for insulin resistance (HOMA-IR), C-peptide, and type A1c glycosylated hemoglobin (HbA1c) were all measured at baseline and eight weeks after ingestion of test products in the first (0–8 weeks) and second (12–20 weeks) periods.